Together, the findings in the bone marrow and fat-pad biopsy specimens were diagnostic of systemic immunoglobulin light-chain (AL) amyloidosis (the abnormal deposition of immunoglobulin light ...

Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, announces that the U.S. Food and ...

Int J Clin Rheumatol. 2009;4(2):171-188. A completely different approach is to look for new drugs that may be able to interfere with amyloid deposition or to stimulate removal of amyloid deposits.

According to GlobalData, Phase II drugs for Systemic Lupus Erythematosus have a 39% phase ... for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis. Johnson & Johnson ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

The coexistence of transthyretin cardiac amyloidosis (ATTR‐CA) and aortic stenosis (AS) is increasingly recognized, but the clinical consequences are unclear. We aimed to characterize clinical ...

As his career progressed, the actor gained a deeper understanding of the lasting effects of slavery through the systemic racism he says he faced over his 30-year journey in the industry.

NAPLES, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative products to improve the lives of patients with systemic amyloidosis ...

Physical examination reveals well-demarcated hyperpigmented macules. Macular amyloidosis is the result of extracellular amyloid deposition within the skin. 1 Severe pruritus is often the presenting ...